Product Program year 2024 Source: CMS Open Payments

Eversense E3 Sensor Kit - Retail

Device Diabetes

PDI 00817491022967

Open in the dashboard

General payments

$199,461

2,748 payments

Research payments

$0

0 payments

Through program year 2024, $199,461 in general payments and $0 in research payments were reported against Eversense E3 Sensor Kit - Retail (Diabetes).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $199,461 2,748

Breakdown

Who paid General payments · program year 2024
  1. Ascensia Diabetes Care US Inc. $199,461 2,748 payments
Top recipients General payments · program year 2024
  1. Mark Corriere Internal Medicine · Columbia, MD $12,065 6% · 8 payments
  2. Amir Harari Endocrinology, Diabetes & Metabolism · Scottsdale, AZ $10,528 5% · 10 payments
  3. Kelsey Furr Nurse Practitioner · West Jordan, UT $9,270 5% · 34 payments
  4. David Ahn Endocrinology, Diabetes & Metabolism · Newport Beach, CA $8,695 4% · 16 payments
  5. Gary Graf Nurse Practitioner · Topeka, KS $6,656 3% · 18 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $76,593 39% · 480 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $38,338 19% · 236 practitioners
  3. Nurse Practitioner $25,995 13% · 82 practitioners
  4. Internal Medicine $23,362 12% · 102 practitioners
  5. Family Medicine $7,397 4% · 105 practitioners

The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $22,441 11% · 116 recipients
  2. California $21,240 11% · 153 recipients
  3. Florida $14,114 7% · 106 recipients
  4. Arizona $13,461 7% · 60 recipients
  5. Maryland $13,071 7% · 6 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

2,748 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record